890-38-0
基本信息
2ˊ-脱氧肌苷
9-(2-脱氧-Β-D-呋喃核糖基)次黄嘌呤
9-(2-DEOXY-BETA-D-RIBOFURANOSYL)HYPOXANTHINE
DEOXYINOSINE, 2'-
DI
2’-deoxy-inosin
Deoxyinosine
Hypoxanthine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-
9-(2-deoxy-β-d-ribofuranosyl)hypoxanthine
2'-Deoxy-D-inosine
9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
DEOXYINOSINE, 2'-(P)
2''-DEOXYINOSINE Crystalline
9-(4-Hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1,9-dihydropurin-6-one
2-DEOXYINOSINE extrapure
9-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
Inosine, 2'-deoxy-
物理化学性质
外观性状 | 白色粉末,可溶于甲醇、乙醇、DMSO等有机溶剂。 |
熔点 | 250 °C |
比旋光度 | 21 º (c=1, H2O 22 ºC) |
沸点 | 395.4°C (rough estimate) |
密度 | 1.3402 (rough estimate) |
折射率 | -16 ° (C=1, H2O) |
储存条件 | −20°C |
溶解度 | DMSO (Slightly), Waterh (Slightly) |
酸度系数(pKa) | 8.92±0.70(Predicted) |
形态 | 粉末 |
颜色 | 白色至灰白色 |
水溶解性 | 8.33g/L(25.02 ºC) |
BRN | 33517 |
InChI | InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1 |
InChIKey | VGONTNSXDCQUGY-RRKCRQDMSA-N |
SMILES | OC[C@H]1O[C@@H](N2C3C(=C(N=CN=3)O)N=C2)C[C@@H]1O |
CAS 数据库 | 890-38-0(CAS DataBase Reference) |
NIST化学物质信息 | Inosine, 2'-deoxy-(890-38-0) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H302-H315-H319 |
防范说明 | P261-P305+P351+P338 |
危险品标志 | Xn,Xi |
危险类别码 | 20/21/22-36/37/38 |
安全说明 | S24/25 |
WGK Germany | 3 |
F | 10-23 |
海关编码 | 29349990 |
图谱信息
2'-脱氧肌苷(890-38-0)质谱(MS)2'-脱氧肌苷(890-38-0)核磁图(1HNMR)2'-脱氧肌苷(890-38-0)核磁图(13CNMR)2'-脱氧肌苷(890-38-0)红外图谱(IR1)2'-脱氧肌苷(890-38-0)红外图谱(IR2)2'-脱氧肌苷(890-38-0)Raman光谱知名试剂公司产品信息
2'-Deoxyinosine,>98.0%(LC)(T)(890-38-0) TCI Shanghai
2'-脱氧肌苷价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/11 | XW89038003 | 2’-脱氧肌苷 | 890-38-0 | 5G | 255元 |
2024/11/11 | XW89038002 | 2’-脱氧肌苷 | 890-38-0 | 250MG | 36元 |
2024/11/11 | XW89038001 | 2’-脱氧肌苷 | 890-38-0 | 1G | 73元 |
常见问题列表
Human Endogenous Metabolite
|
In the absence of deoxycoformycin, 2’-deoxyadenosine is primarily deaminated to 2’-deoxyinosine and then converted into hypoxanthine. In the presence of the inhibitor, the deoxynucleoside, in addition to a phosphorylation process, undergoes phosphorolytic cleavage giving rise to adenine. The conversion of 2’-deoxyadenosine to adenine might represent a protective device, emerging when the activity of adenosine deaminase is reduced or inhibited. There is much evidence to indicate that the enzyme catalyzing this processs may be distinct from methylthioadenosine phosphorylase and S-adenosyl homocysteine hydrolase, which are the enzymes reported to be responsible for the formation of adenine from 28-deoxyadenosine in mammals.